Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CG Oncology, Inc. (CGON)
NASDAQ:CGON
RESEARCH TOOLSreports
Holding CGON?
Track your performance easily
CG Oncology, Inc. (CGON) Ownership Overview
15.68% Insiders
8.08% Mutual Funds
50.15% Other Institutional Investors
26.08% Public Companies and
Individual Investors
The ownership structure of CG Oncology, Inc. (CGON) stock is a mix of institutional, retail and individual investors. Approximately 58.24% of the company’s stock is owned by Institutional Investors, 15.68% is owned by Insiders and 26.08% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 31, 2024 | Roche Corleen M. Cfo & Secretary | xxxxxxxxxxxxx | $38000 |
| Jan 31, 2024 | Vijay Kasturi Chief Medical Officer | xxxxxxxxxxxxx | $24985 |
| Jan 31, 2024 | Hong Fang Song Director | xxxxxxxxxxxxx | $4999983 |
| Jan 31, 2024 | xxxxxxxxxxxxx | $7600000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $3376443 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $13686857 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $23162751 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $44116959 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,174,141 | Institution | 3.24% | 80,486,700 | |
| 2,055,834 | Institution | 3.06% | 76,106,975 | |
| 1,397,433 | Institution | 2.08% | 51,732,970 | |
| 869,103 | Institution | 1.30% | 32,174,193 | |
| 733,695 | Institution | 1.09% | 27,161,389 | |
| 650,400 | Institution | 0.97% | 24,077,808 | |
| 586,706 | Institution | 0.87% | 21,719,856 | |
| 525,199 | Institution | 0.78% | 19,442,867 | |
| 510,660 | Institution | 0.76% | 18,904,633 | |
| 433,540 | Institution | 0.65% | 16,049,651 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,055,834 | Institution | 3.06% | 76,106,975 | |
| 650,400 | Institution | 0.97% | 24,077,808 | |
| 510,660 | Institution | 0.76% | 18,904,633 | |
| 302,637 | Institution | 0.45% | 11,203,622 | |
| 280,935 | Institution | 0.42% | 10,400,214 | |
| 247,428 | Institution | 0.37% | 9,159,785 | |
| 212,536 | Institution | 0.32% | 7,868,083 | |
| 198,575 | Institution | 0.30% | 7,351,247 | |
| 171,101 | Institution | 0.26% | 6,334,159 | |
| 152,436 | Institution | 0.23% | 5,643,181 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 754,915 | Institution | 1.13% | 25,176,415 | |
| 613,379 | Institution | 0.91% | 22,707,291 | |
| 555,200 | Institution | 0.83% | 19,948,336 | |
| 586,479 | Institution | 0.87% | 19,559,075 | |
| 395,600 | Institution | 0.59% | 13,193,260 | |
| 323,979 | Institution | 0.48% | 10,804,700 | |
| 125,409 | Institution | 0.19% | 4,642,641 | |
| 100,900 | Institution | 0.15% | 3,625,337 | |
| 86,068 | Institution | 0.13% | 3,186,237 | |
| 91,813 | Institution | 0.14% | 3,061,964 |
FAQ
Who Owns CG Oncology, Inc. (CGON)?
According to the latest TipRanks data, approximately 50.15% of the company's stock is held by institutional investors, 15.68% is held by insiders, and 26.08% is held by retail investors.
What percentage of CG Oncology, Inc. (CGON) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.15% of CG Oncology, Inc. (CGON) stock is held by institutional investors.
What percentage of CG Oncology, Inc. (CGON) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.08% of CG Oncology, Inc. (CGON) stock is held by retail investors.
Who owns the most shares of CG Oncology, Inc. (CGON)?
Vanguard owns the most shares of CG Oncology, Inc. (CGON).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.